Valion Bio Highlights Previously Announced Completion Of Formulation Work On Needle-Free Oral Version Of Acute Radiation Syndrome Drug Entolimod
Share
Why It Matters
Valion Bio finished work on a needle-free pill version of its radiation medicine. When a company reaches a development milestone, watch if they move toward real patient tests next.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.